Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Farmstandart OAO Announces Completion Of Transaction To Acquire Bever Pharmaceutical Pte Ltd


Thursday, 22 Aug 2013 10:10am EDT 

Farmstandart OAO announced that the completion of the transaction to acquire a 100% share capital in Bever Pharmaceutical Pte Ltd (Singapore) (Bever) (the Transaction). The amount of the transaction is USD590million. The Transaction will be funded by the combination of Pharmstandard's shares and GDRs owned by Pharmstandard-Leksredstva OJSC in the amount of USD542 million (price per share of RUB2,235.4 and price per GDR of USD20.76) and cash of USD48 million, which may be financed from external sources. Pharmstandard-Leksredstva OJSC currently holds Pharmstandard's shares and GDRs on its balance sheet at approximately USD475 million. 

Latest Developments for Sanofi Aventis Pakistan Ltd

Company Quote

788.0
6.0 +0.77%
24 Jul 2014